Algernon Closes First Tranche of its Recently Announced Private Placement Financing
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Akari Therapeutics Releases Virtual Investor What This Means Segment Highlighting its Recently Granted India Patent
June 25, 2025 09:00 ET | Source: Akari Therapeutics Plc Access the…
